Cbfβ interacts with RUNX2 and has a critical role in bone development

Nature Genetics

Volumn 32, Issue 4, 2002, Pages 639-644

  Kundu, Mondira ^a   Javed, Amjad ^b   Jeon, Jae Pil ^a   Horner, Alan ^c   Shum, Lillian ^c   Eckhaus, Michael ^a   Muenke, Maximilian ^a   Lian, Jane B ^b   Yang, Yingzi ^a   Nuckolls, Glen H ^c   Stein, Gary S ^b   Liu, P Paul ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CORE BINDING FACTOR; GREEN FLUORESCENT PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; CBFB PROTEIN, HUMAN; CBFB PROTEIN, MOUSE; CORE BINDING FACTOR BETA; DNA BINDING PROTEIN; HYBRID PROTEIN; PHOTOPROTEIN; RUNX2 PROTEIN, HUMAN; RUNX2 PROTEIN, MOUSE; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR RUNX; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIRTH; BONE DEVELOPMENT; CARTILAGE CELL; CELL DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; CONTROLLED STUDY; DISEASE SEVERITY; ENCHONDRAL OSSIFICATION; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENE MUTATION; GENETIC CODE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LETHALITY; LIFESPAN; MOUSE; MOUSE STRAIN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; STEM CELL; ALLELE; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HELA CELL; HOMOZYGOTE; LETHAL GENE; METABOLISM; PHENOTYPE; PHYSIOLOGY; PLURIPOTENT STEM CELL; PRENATAL DEVELOPMENT; TRANSGENIC MOUSE;

ANIMALIA;

ALLELES; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CORE BINDING FACTOR ALPHA SUBUNITS; CORE BINDING FACTOR BETA SUBUNIT; CORE BINDING FACTORS; DNA-BINDING PROTEINS; EMBRYONIC AND FETAL DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, LETHAL; GREEN FLUORESCENT PROTEINS; HELA CELLS; HOMOZYGOTE; HUMANS; LUMINESCENT PROTEINS; MICE; MICE, TRANSGENIC; NEOPLASM PROTEINS; OSTEOGENESIS; PHENOTYPE; PLURIPOTENT STEM CELLS; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 18744362426     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1050     Document Type: Article

References (32)

1. Mundlos, S. Cleidocranial dysplasia: Clinical and molecular genetics. J. Med. Genet. 36, 177-182 (1999).
2. Zhou, G. et al. CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia. Hum. Mol. Genet. 8, 2311-2316 (1999)
3. Wang, Q. et al. The CBFβ subunit is essential for CBFα2 (AML1) function in vivo Cell 87, 697-708 (1996).
4. Sasaki, K. et al. Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core-binding factor β. Proc. Natl. Acad. Sci. USA 93, 12359-12363 (1996).
5. Kundu, M. et al. Role of Cbfb in hematopoiesis and perturbations resulting from expression of the leukemogenic fusion gene Cbfb-MYH11. Blood 100, 2449-2456 (2002).
6. Komori, T. et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755-764 (1997).
7. Otto, F. et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765-771 (1997).
8. Kagoshima, H., Akamatsu, Y., Ito, Y. & Shigesada, K. Functional dissection of the α and β subunits of transcription factor PEBP2 and the redox susceptibility of its DNA binding activity. J. Biol. Chem. 271, 33074-33082 (1996).
9. Miller, J.D., Stacy, T., Liu, P.P. & Speck, N.A. Core-binding factor β (CBFβ), but not CBFβ-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBFβ-deficient embryonic stem cells. Blood 97, 2248-2256 (2001).
10. Kim, I.S., Otto, F., Zabel, B. & Mundlos, S. Regulation of chondrocyte differentiation by Cbfa1. Mech. Dev. 80, 159-170 (1999).
11. Zhang, Y.W. et al. A RUNX2/PEBP2α A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc. Natl. Acad. Sci. USA 97, 10549-10554 (2000).
12. Harada, H. et al. Cbfa1 isoforms exert functional differences in osteoblast differentiation. J. Biol. Chem. 274, 6972-6978 (1999).
13. Otto, F., Kanegane, H. & Mundlos, S. Mutations in the RUNX2 gene in patients with cleidocranial dysplasia. Hum. Mutat. 19, 209-216 (2002).
14. Tahirov, T.H. et al. Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFβ. Cell 104, 755-767 (2001).
15. Warren, A.J., Bravo, J., Williams, R.L. & Rabbitts, T.H. Structural basis for the heterodimeric interaction between the acute leukaemia-associated transcription factors AML1 and CBFβ. EMBO J. 19, 3004-3015 (2000).
16. Thirunavukkarasu, K., Mahajan, M., McLarren, K.W., Stifani, S. & Karsenty, G. Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfβ. Mol. Cell. Biol. 18, 4197-4208 (1998).
17. Prince, M. et al. Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts. J. Cell. Biochem. 80, 424-440 (2001).
18. Javed, A. et al. Runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: Evidence for promoter context-dependent activity of Cbfa proteins. Mol. Cell. Biol. 21, 2891-2905 (2001).
19. Hanai, J. et al. Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter. J. Biol. Chem. 274, 31577-31582 (1999).
20. Shirakabe, K., Terasawa, K., Miyama, K., Shibuya, H. & Nishida, E. Regulation of the activity of the transcription factor Runx2 by two homeobox proteins, Msx2 and Dlx5. Genes Cells 6, 851-856 (2001).
21. Javed, A. etal. Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBFα/AML/PEBP2α) dependent activation of tissue-specific gene transcription. J. Cell. Sci. 113, 2221-2231 (2000).
22. D'Alonzo, R.C., Selvamurugan, N., Karsenty, G. & Partridge, N.C. Physical interaction of the activator protein-1 factors c-Fos and c-Jun with Cbfa1 for collagenase-3 promoter activation. J. Biol. Chem. 277, 816-822 (2002).
23. Gutierrez, S. et al. CCAAT/enhancer-binding proteins (C/EBP) β and Δ activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. J. Biol. Chem. 277, 1316-1323 (2002).
24. Speck, N.A. & Gilliland, D.G. Core-binding factors in haematopoiesis and leukaemia. Nature Rev. Cancer 2, 502-513 (2002).
25. Yoshida, T. et al. Functional analysis of RUNX2 mutations in Japanese patients with cleidocranial dysplasia demonstrates novel genotype-phenotype correlations. Am. J. Hum. Genet. 71, 724-738 (2002).
26. Miller, J. et al. The core-binding factor β subunit is required for bone formation and hematopoietic maturation. Nature Genet. 32, 645-649 (2002).
27. Yoshida, C.A. et al. Core-binding factor β interacts with Runx2 and is required for skeletal development. Nature Genet. 32, 633-638 (2002).
28. St-Jacques, B., Hammerschmidt, M. & McMahon, A.P. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev. 13, 2072-2086 (1999).
29. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A.L. & Karsenty, G. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89, 747-754 (1997).
30. Meyers, S., Lenny, N., Sun, W. & Hiebert, S.W. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia. Oncogene 13, 303-312 (1996).
31. Adya, N., Stacy, T., Speck, N.A. & Liu, P.P. The leukemic protein core-binding factor β (CBFβ)-smooth-muscle myosin heavy chain sequesters CBFα2 into cytoskeletal filaments and aggregates. Mol. Cell. Biol. 18, 7432-7443 (1998).
32. Banerjee, C. et al. Differential regulation of the two principal Runx2/Cbfa1 N-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype. Endocrinology 142, 4026-4039 (2001).